Casdin Capital »

Qiagen NV Ord Shares shares owned by Casdin Capital

Quarter-by-quarter ownership of Qiagen NV Ord Shares (QGEN) shares owned by Casdin Capital from 13F filings

Historical chart of Casdin Capital investment in Qiagen NV Ord Shares

Tip: Access up to 7 years of quarterly data

All positions including Qiagen NV Ord Shares held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Qiagen NV Ord Shares by Casdin Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $14M 360k 40.04

More positions owned by Casdin Capital

Revolution Medicines (RVMD)
Genedx Holdings Corp Com Cl A (WGS)
Relay Therapeutics (RLAY)
Biolife Solutions Com New (BLFS)
D Fluidigm Corp Del (LAB)
Illumina (ILMN)
Structure Therapeutics Sponsored Ads (GPCR)
10x Genomics Cl A Com (TXG)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Guardant Health (GH)
Neurogene (NGNE)
Alnylam Pharmaceuticals (ALNY)
Maze Therapeatics (MAZE)
Scholar Rock Hldg Corp (SRRK)

View all positions for Casdin Capital

Top funds holding Qiagen NV Ord Shares

Vanguard Capital Management
Deutsche Bank Aktiengesellschaft
BlackRock
Amundi
Morgan Stanley
Earnest Partners
Robeco Investment Management
Bank of America Corporation
Fivespan Partners
Allspring Global Investments Holdings
Capital Research and Management Company - Division 3
Goldman Sachs Group
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Citigroup
Helikon Investments

View all funds holding Qiagen NV Ord Shares